![Channel Therapeutics Corporation](/common/images/company/A_CHRO.png)
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.3788 | 23.8238993711 | 1.59 | 1.97 | 1.2203 | 104688 | 1.51143845 | CS |
4 | 0.8788 | 80.623853211 | 1.09 | 3.8 | 1 | 2731629 | 2.41639114 | CS |
12 | 1.3498 | 218.061389338 | 0.619 | 3.8 | 0.5513 | 1004703 | 2.26070251 | CS |
26 | 1.1788 | 149.215189873 | 0.79 | 3.8 | 0.45 | 499939 | 2.06783736 | CS |
52 | -4.0312 | -67.1866666667 | 6 | 6 | 0.45 | 266381 | 2.06836967 | CS |
156 | -4.0312 | -67.1866666667 | 6 | 6 | 0.45 | 266381 | 2.06836967 | CS |
260 | -4.0312 | -67.1866666667 | 6 | 6 | 0.45 | 266381 | 2.06836967 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約